Inhibrx Biosciences Inc's total assets for Q2 2025 were $212.12M, a decrease of -12.58% from the previous quarter. INBX total liabilities were $143.56M for the fiscal quarter, a -3.13% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.